Showing results (101-110 of 170) with videos related to
Sort By:
Pageof 17
JCO Global Oncology|November 5, 2025
Late Presentation and Treatment Outcomes of Gastric Carcinoma in Jordanian PopulationHikmat Abdel-Razeq, Maha Barbar, Rashid Abdel-Razeq, et al.Journal of Clinical Medicine|December 9, 2023
Survival Outcomes after Placement of Inferior Vena Cava Filters in Cancer Patients: Insights from a Comprehensive Cancer Center's ExperienceHikmat Abdel-Razeq, Faris Tamimi, Mohammed J Al-Jaghbeer, et al.Cancer Management and Research|December 11, 2019
Clinicopathological Characteristics And Treatment Outcomes Of Breast Cancer Among Adolescents And Young Adults In A Developing CountryHikmat Abdel-Razeq, Hanan Almasri, Fadwa Abdel Rahman, et al.Irish Journal of Medical Science|January 28, 2022
The efficacy of a comprehensive bone health program in maintaining bone mineral density in postmenopausal women with early-stage breast cancer treated with endocrine therapy: real-world dataHikmat Abdel-Razeq, Ula Al-Rasheed, Noor Mashhadani, et al.Oncotargets and Therapy|April 27, 2018
Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patientsHikmat Abdel-Razeq, Salwa S Saadeh, Mahmoud Abu-Nasser, et al.Breast Cancer Research and Treatment|July 2, 2017
From clinical trials to clinical practice: outcome of NSABP-B27 neoadjuvant chemotherapy regimen for high-risk early-stage breast cancerHikmat Abdel-Razeq, Lina Marei, Salwa S Saadeh, et al.JCO Global Oncology|April 16, 2025
Analysis of the Demand and Supply for Oncology Workforce in Jordan: Current Status and Future ProjectionsAhmed Salem, Layth Al-Ramahi, Sami Alodeh, et al.Scientific Reports|June 4, 2024
Genetic counseling and genetic testing for pathogenic germline mutations among high-risk patients previously diagnosed with breast cancer: a traceback approachHikmat Abdel-Razeq, Faris Tamimi, Sereen Iweir, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 30, 2021
The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell LymphomaHikmat Abdel-Razeq, Mohammad Ma'koseh, Asem Mansour, et al.Journal of Clinical Medicine|January 23, 2024
The Application of Existing Risk Assessment Models (RAMS) to Predict the Occurrence of Venous Thromboembolic Events among Patients with Classic Hodgkin LymphomaMohammad Ma'koseh, Alaa Abufara, Dana Albaghdadi, et al.Pageof 17